Mouse models have been the workhorses of preclinical immuno-oncology (IO) research, and advances in mouse model development have expanded to applications for nearly all types of solid tumors and hematological malignancies. Preclinical evaluation of experimental immunotherapies has been advanced by syngeneic and humanized mouse models.
New Blog: Choosing the RIGHT Model - Syngeneic versus Humanized Mouse Models
Feb 2, 2023 11:49:07 AM / by Champions Oncology posted in Syngeneic Models, Immuno-Oncology, Humanized Models